Valuation Genomma Lab Internacional, S.A.B. de C.V.

Stocks

End-of-day quote Mexican S.E. Other stock markets 23/07/2026			5-day change	1st Jan Change
14.06 ^MXN	-3.17%		-5.38%	-21.41%

07-24	Genomma Lab Internacional, S.A.B. de C.V., Q2 2026 Earnings Call, Jul 23, 2026
07-23	Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	21,614	16,849	13,161	23,244	17,474	13,712	-	-
Change	-	-22.05%	-21.89%	76.61%	-24.82%	-21.53%	-	-
Enterprise Value (EV) ¹	26,264	21,719	17,681	27,294	22,241	17,568	17,271	16,549
Change	-	-17.3%	-18.59%	54.37%	-18.51%	-21.01%	-1.69%	-4.18%
P/E	14.9x	12x	13.1x	11.7x	11.1x	6.99x	6.59x	5.8x
PBR	1.96x	1.75x	1.44x	2.26x	1.57x	0.97x	-	-
PEG	-	-5.76x	-0.6x	0.1x	-0.4x	0.3x	1.09x	0.4x
Capitalization / Revenue	1.4x	1x	0.8x	1.25x	1x	0.76x	0.71x	0.67x
EV / Revenue	1.7x	1.29x	1.07x	1.47x	1.27x	0.97x	0.9x	0.81x
EV / EBITDA	8.18x	6.26x	5.12x	6.3x	5.42x	4.19x	3.88x	3.49x
EV / EBIT	8.57x	6.66x	5.48x	6.85x	5.92x	4.59x	4.26x	3.82x
EV / FCF	32.1x	13.4x	8.81x	9.77x	14.8x	7.43x	8.47x	7.14x
FCF Yield	3.11%	7.49%	11.4%	10.2%	6.77%	13.5%	11.8%	14%
Dividend per Share ²	0.3817	0.3817	0.1961	0.8	0.8	0.8342	1.232	1.585
Rate of return	1.78%	2.25%	1.38%	3.18%	4.47%	5.93%	8.76%	11.3%
EPS ²	1.44	1.41	1.08	2.14	1.61	2.011	2.132	2.425
Distribution rate	26.5%	27.1%	18.2%	37.4%	49.7%	41.5%	57.8%	65.4%
Net sales ¹	15,460	16,859	16,467	18,607	17,541	18,097	19,192	20,345
EBITDA ¹	3,210	3,471	3,454	4,330	4,101	4,190	4,448	4,745
EBIT ¹	3,063	3,263	3,224	3,982	3,760	3,828	4,052	4,328
Net income ¹	1,451	1,397	1,031	2,137	1,607	2,004	2,177	2,457
Net Debt ¹	4,650	4,870	4,520	4,050	4,768	3,856	3,559	2,837
Reference price ²	21.48	16.94	14.16	25.13	17.89	14.06	14.06	14.06
Nbr of stocks (in thousands)	1,006,240	994,639	929,461	924,946	976,728	975,253	-	-
Announcement Date	2/23/22 A	2/22/23 A	2/21/24 A	2/26/25 A	2/25/26 A	-	-	-

¹MXN in Million²MXN

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.	6.99x	0.97x	4.19x	5.93%	783M
ELI LILLY AND COMPANY	35.39x	12.58x	26.43x	0.57%	1,057B
JOHNSON & JOHNSON	27.79x	6.35x	17.58x	2.07%	624B
ABBVIE INC.	33.47x	7.59x	15.59x	2.68%	454B
ROCHE HOLDING AG	20.98x	4.63x	11.4x	2.86%	341B
NOVARTIS AG	21.62x	5.7x	13.97x	2.82%	297B
ASTRAZENECA PLC	21.08x	4.45x	12.3x	1.98%	262B
NOVO NORDISK A/S	14.13x	5.26x	10.83x	3.54%	215B
AMGEN INC.	24.37x	6.41x	11.32x	2.71%	201B
GILEAD SCIENCES, INC.	-47.14x	5.65x	31.2x	2.52%	162B
Average	15.87x	5.96x	15.48x	2.77%	361.47B
Weighted average by Cap.	24.72x	7.88x	18.52x	1.98%